吸入用丙酸倍氯米松和布地奈德治疗哮喘的疗效。 - Suppr

Suppr

超能文献

Efficacy of inhaled beclomethasone dipropionate and budesonide in the treatment of asthma.

作者信息

Webb D R

机构信息

University of Washington, Seattle, USA.

出版信息

Respir Med. 1998 Jul;92 Suppl B:7-14. doi: 10.1016/s0954-6111(98)90435-8.

DOI:10.1016/s0954-6111(98)90435-8

PMID:10193530

Abstract

摘要

相似文献

Efficacy of inhaled beclomethasone dipropionate and budesonide in the treatment of asthma.吸入用丙酸倍氯米松和布地奈德治疗哮喘的疗效。

Respir Med. 1998 Jul;92 Suppl B:7-14. doi: 10.1016/s0954-6111(98)90435-8.

Effect of inhaled beclomethasone dipropionate and budesonide on adrenal function, skin changes and cataract formation.

Respir Med. 1998 Jul;92 Suppl B:15-23. doi: 10.1016/s0954-6111(98)90436-x.

Inhaled corticosteroids are considered by many to be the most effective therapy.许多人认为吸入性皮质类固醇是最有效的治疗方法。

Respir Med. 1998 Jul;92 Suppl B:1.

Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.吸入用丙酸倍氯米松和布地奈德干粉对成年哮喘患者肺功能及血清嗜酸性粒细胞阳离子蛋白的影响

J Investig Allergol Clin Immunol. 1999 Jul-Aug;9(4):241-7.

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.吸入用环索奈德与吸入用布地奈德、吸入用倍氯米松或吸入用氟替卡松治疗成人慢性哮喘的系统评价

BMC Fam Pract. 2006 Jun 5;7:34. doi: 10.1186/1471-2296-7-34.

Effect of inhaled beclomethasone dipropionate and budesonide on growth in children with asthma.吸入用二丙酸倍氯米松和布地奈德对哮喘儿童生长发育的影响。

Respir Med. 1998 Jul;92 Suppl B:37-45. doi: 10.1016/s0954-6111(98)90438-3.

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.丙酸氟替卡松治疗哮喘的临床经验：与布地奈德和二丙酸倍氯米松在半微克剂量或更低剂量下的疗效和全身活性的荟萃分析。

Respir Med. 1998 Jan;92(1):95-104. doi: 10.1016/s0954-6111(98)90039-7.

Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.不同丙酸倍氯米松制剂治疗哮喘1年期间的生长发育、全身安全性及疗效：一项针对儿童的超细气雾剂与传统气雾剂的开放标签随机对照研究。

Pediatrics. 2002 Jun;109(6):e92. doi: 10.1542/peds.109.6.e92.

Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma.在轻至中度哮喘患者中，比较每日一次使用布地奈德都保与使用压力定量吸入器每日两次吸入双倍剂量丙酸倍氯米松的疗效和安全性。

West Afr J Med. 2005 Jul-Sep;24(3):190-5. doi: 10.4314/wajm.v24i3.28197.

Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.吸入性氟替卡松与吸入性倍氯米松或吸入性布地奈德用于成人和儿童慢性哮喘的治疗比较

Cochrane Database Syst Rev. 2005 Apr 18(2):CD002310. doi: 10.1002/14651858.CD002310.pub3.

引用本文的文献

Biophysical interaction between corticosteroids and natural surfactant preparation: implications for pulmonary drug delivery using surfactant a a carrier.皮质类固醇与天然表面活性剂制剂之间的生物物理相互作用：对使用表面活性剂作为载体进行肺部药物递送的影响。

Soft Matter. 2012 Jan 14;8(2):504-511. doi: 10.1039/c1sm06444d. Epub 2011 Nov 1.

Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.通过含氢氟烷烃装置递送的吸入用丙酸倍氯米松的药代动力学和药效学特性。

Clin Pharmacokinet. 2005;44(8):815-36. doi: 10.2165/00003088-200544080-00004.

Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment.每日一次吸入性糖皮质激素治疗轻度至中度哮喘：提高治疗依从性

Drugs. 1999;58 Suppl 4:25-33; discussion 52. doi: 10.2165/00003495-199958004-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验